LASIX

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Singapore, Turkey, United States, South Africa

Active ingredients

The drug LASIX contains one active pharmaceutical ingredient (API):

1 Furosemide UNII 7LXU5N7ZO5 - FUROSEMIDE

Furosemide inhibits active chloride transport in the thick ascending limb. Re-absorption of sodium, chloride from the nephron is reduced and a hypotonic or isotonic urine produced. The evidence from many experimental studies suggests that furosemide acts along the entire nephron with the exception of the distal exchange site. Read about Furosemide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LASIX Solution for injection or infusion	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C03CA01	Furosemide	C Cardiovascular system → C03 Diuretics → C03C High-ceiling diuretics → C03CA Sulfonamides, plain
Discover more medicines within C03CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 12222G, 1810G, 2411X, 2412Y, 2413B, 3466K
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502807301157313, 502807302110310, 576720040061617, 576720040061717
Country: CA	Health Products and Food Branch	Identifier(s): 02224720, 02224755
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01097929, 01463535, 01463541, 01595774, 02510969, 04686276, 04686299
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28797-03-09
Country: EE	Ravimiamet	Identifier(s): 1039362, 1738245, 1825321
Country: HK	Department of Health Drug Office	Identifier(s): 05565, 05566, 59962
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-797987648
Country: IE	Health Products Regulatory Authority	Identifier(s): 30856
Country: IT	Agenzia del Farmaco	Identifier(s): 020465011, 023993013, 023993037, 023993049
Country: JP	医薬品医療機器総合機構	Identifier(s): 2139005F1052, 2139005F2342, 2139005F3039, 2139401A1033, 2139401A2137
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003666, 1015558, 1086333
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 62267, 62270
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 20877, 33936
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 315, 317
Country: SG	Health Sciences Authority	Identifier(s): 00199P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699809014008, 8699809018754, 8699809754003, 8699809759206, 8699809759213
Country: US	FDA, National Drug Code	Identifier(s): 30698-060, 30698-066, 30698-067
Country: ZA	Health Products Regulatory Authority	Identifier(s): D/18.1/266, E/18.1/201, E/18.1/202, J/18.1/5, N/18.1/6, V/18.1/9